BioSpace News Archive

RS Oncology presents new drug in early clinical development for Mesothelioma and lung cancer patients

RS Oncology is bringing exciting new science to patients who will have the best chance of benefiting from new therapies. PRX3 is a novel drug target with potential for treating patients with the asbestos related cancer, mesothelioma.

August 3, 2023
·
3 min read
Femasys Initiates Enrollment in Pivotal Trial of its Permanent Birth Control Candidate FemBloc- First of its kind, non-surgical, permanent birth control option begins enrollment in landmark trial -

Femasys Inc. announced the initiation of enrollment in a prospective multi-center pivotal trial for FemBloc INtratubal Occlusion for TranscervicAL PErmanent Birth Control (the “FINALE” trial), to investigate the safety and efficacy of its investigational permanent birth control candidate, FemBloc®.

August 3, 2023
·
6 min read
Business

Moleculin to Report Second Quarter Financial Results on August 11, 2023 and Host Conference Call and Webcast

Moleculin Biotech, Inc. today announced that it will report its financial results for the second quarter ended June 30, 2023 , on Friday, August 11, 2023.

August 3, 2023
·
2 min read
Business

DarioHealth to Report Second Quarter 2023 Results on Thursday, August 10th

DarioHealth Corp. announced that it will release its financial results for the second quarter ended June 30, 2023, on Thursday, August 10, 2023, before market opens and will host a conference call and webcast at 8:30 am Eastern Time.

August 3, 2023
·
2 min read
BioCapital

Shuttle Pharmaceuticals Completes Manufacturing of Active Pharmaceutical Ingredient (API) for Use in Clinical Trial

Shuttle Pharmaceuticals Holdings, Inc. announced that TCG GreenChem has successfully completed the initial manufacturing campaign for the active pharmaceutical ingredient of Ropidoxuridine for use in the Company’s upcoming Phase II clinical trial in brain cancer patients undergoing radiation therapy.

August 3, 2023
·
3 min read
Business

Know Labs, Inc. to Host Review of Third Quarter Fiscal Year 2023 Results on August 14, 2023

Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates and results for its third quarter of the fiscal year 2023 ended on June 30, 2023, on August 14, 2023, beginning at 1:30 pm PT.

August 3, 2023
·
3 min read
Business

Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board

Sonoma Pharmaceuticals, Inc. today announced the appointment of Dr. Hye Jin Chung MD, MMSc, Assistant Professor of Dermatology at Harvard Medical School in Boston and practicing dermatologist at Beth Israel Deaconess Medical Center, to the company’s Scientific Advisory Board.

August 3, 2023
·
5 min read
Business

Immunocore to report second quarter 2023 financial results and host call on August 10, 2023

Immunocore Holdings Plc announced that it will report second quarter financial results, before the US markets open on Thursday, August 10, 2023.

August 3, 2023
·
1 min read
Genetown

BrainsWay Announces Publication of Three New Deep TMS Research Publications

BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced three recent publications highlighting its Deep Transcranial Magnetic Stimulation in leading peer-reviewed medical journals.

August 3, 2023
·
5 min read
Business

Daré Bioscience to Host Second Quarter 2023 Financial Results and Company Update Conference Call and Webcast on August 10, 2023

Daré Bioscience, Inc., a leader in women’s health innovation, announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, August 10, 2023, to review its financial results for the quarter ended June 30, 2023 and to provide a Company update.

August 3, 2023
·
3 min read